Inflammatory Bowel Disease 1. Describe the pathopysiology of the disease you have chosen – What is the spectrum of disease/pathology the disease? Is the disease characterized by inflammation, etc? Is it an infectious and/or chronic disease? If so what is the agent, its reservoir, mode of transmission etc. Inflammatory bowel disease is a chronic illness characterized by inflammation in the gastrointestinal tract (Wolf, CDC, Mayo clinic, health direct, NHS choices). Patients suffering from inflammatory
The term Inflammatory Bowel Disease (IBD) is a general name given to a few disorders that all fall under the category of inflamed intestines (they become red and swollen.) This is usually due to a reaction the body causes against its own intestinal tissue. The two most common types of Inflammatory Bowel Disease are Ulcerative Colitis (UC) and Crohn’s Disease (CD). Crohn’s disease can affect any part of the gastrointestinal tract; however, it more commonly affects the small intestine or colon. Inflammatory
Crohn’s disease is an inflammatory bowel disease that is defined by inflammation of the digestive system. It can affect any part of the GI tract, including the mouth and anus (Abbvie Inc, 2016)). Crohn’s disease does not have a cure and there is no exact cause for the occurring disease. “Since the exact cause of Crohn’s disease is unknown, it has been linked to a combination of environmental factors, immune function and bacterial factors, as well as a patient’s genetic susceptibility to developing
causes and diseases related to these symptoms. It was awkward and unpleasant to deal with the symptoms for him. He felt weak and started to lose weight. Eventually, Mr. A was diagnosed with crohn’s disease (CD) a type of inflammatory bowel disease (IBD) in 2012. IBD is a collective group of disorders that are chronic and incurable and characterised by inflammation in the intestinal tract. (Chang & Johnson, 2014, p.446). Crohn’s disease (CD) and ulcerative colitis (UC) are autoimmune diseases, where the
Inflammatory Bowel Disease (IBD) is a chronic and relapsing gastrointestinal condition currently affecting a total of about 28 million people worldwide (cite). Although it is not considered a fatal condition, painful and disabling symptoms can have a profound detrimental effect on patients’ quality of life. Current understandings behind the etiology of IBD emphasize genetic predispositions to gastrointestinal immune system imbalances. However, pathophysiological understandings of IBD seem to be
fundamental purpose of this paper is to apprise to the reader pivotal information on the inflammatory bowel disorder known as Crohn’s Disease (CD). It is a rare disease that is usually not wanted to be discussed by its sufferers, due to its sensitive nature of being a digestive problem. Luckily, as this paper will show, it is now an issue slowly, but surely, being explored more openly. A short introduction to the chronic disease will be divulged, pathophysiology and etiology will be discussed to prepare the
people diagnosed with inflammatory bowel diseases (IBDs), lactose intolerance and/or a combination of the two. Theories suggest that the delayed onset of lactose intolerance, in patients who already have IBD’s, may arise as secondary lactose intolerance but only as a byproduct of the IBD. This begs the question of if the prevalence of an IBD predisposes that same person to lactose intolerance and if so, what are the drivers that allow this to happen? Inflammatory bowel diseases are categorized into
. Lucendo, A. J., & De Rezende, L. C. Importance of nutrition in inflammatory bowel disease. World Jour of GastroenteroL. 2009. WJG, 15(17), 2081–2088. http://doi.org/10.3748/wjg.15.2081’ This peer review article highlights the fundamental role that nutrition therapy plays in the clinical management of all patients with CD. The review concentrates specially in correcting macro and micronutrient deficiencies in frequently malnourished patients, focusing on reversing the physiopathological consequences
Inflammatory Bowel Disease and Ulcerative Colitis Inflammatory Bowel Disease (IBD) refers to a variety of conditions in which a chronic immune response and inflammation occur throughout the gastrointestinal tract. Inflammatory Bowel Diseases are triggered by an abnormal response by the body’s immune system. In a normal functioning immune system, the cells protect the body from infection. However, in those who are suffering from IBD, the immune system mistakes bacteria, food, and other materials
Crohn’s Disease and the Inflammatory Process Crohn 's disease is an inflammatory process in the intestines that is marked by abnormal inflammation of the GI tract. Crohn’s disease is treated with a variety of single or combined therapies that work at decreasing inflammatory process. Within this essay, I will discuss the etiology and pathophysiology of Crohn’s disease, the evidence- based- practice treatment of Crohn’s and how these medications work in reducing the inflammatory process. I